Patent details

EP2152290 Title: METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES

Basic Information

Publication number:
EP2152290
PCT Application Number:
PCT/US/2008/062015
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP087471884
PCT Publication Number:
WO/2008/134721
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES
French Title of Invention:
MÉTHODES POUR ADMINISTRER DES ANTICORPS ANTI-IL-5
German Title of Invention:
VERFAHREN ZUR VERABREICHUNG VON ANTI-IL-5-ANTIKÖRPERN
SPC Number:

Dates

Filing date:
30/04/2008
Grant date:
04/06/2014
EP Publication Date:
04/06/2014
PCT Publication Date:
06/11/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/02/2010
EP B1 Publication Date:
04/06/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/04/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/01/2018
 
 

Name:
GlaxoSmithKline LLC
Address:
251 Little Falls Drive, Wilmington, DE 19808, United States (US)

History of Owners

From:
30/04/2008
To:
10/01/2018

Name:
GlaxoSmithKline LLC
Address:
Corporation Service Company 2711 Centreville Road Suite 40, Wilmington, Delaware 19808, United States (US)

Agent

Name:
KIRKPATRICK
From:
29/07/2014
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
TOMPSON Debra, J.
Address:
United Kingdom (GB)

2

Name:
ZIA-AMIRHOSSEINI Parnian
Address:
United States (US)

3

Name:
SMITH Deborah
Address:
United States (US)

4

Name:
PATEL Bela, Rajiv
Address:
United States (US)

Priority

1

Priority Number:
914833 P
Priority Date:
30/04/2007
Priority Country:
United States (US)

2

Priority Number:
990715 P
Priority Date:
28/11/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/10;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2018/03
Publication date:
20/02/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20180000011A
Date Registered:
10/01/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Changements de noms et d'adresses
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
GlaxoSmithKline LLC
Address:
251 Little Falls Drive, Wilmington, DE 19808, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/03/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
11/01/2018 Outgoing Correspondence 1
10/01/2018 Request For Change 4